- Home
- TRVI vs NRC Comparison
TRVI vs NRC Comparison
Compare TRVI & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- NRC
- Stock Information
- Founded
- TRVI 2011
- NRC 1981
- Country
- TRVI United States
- NRC United States
- Employees
- TRVI N/A
- NRC N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TRVI Health Care
- NRC Health Care
- Exchange
- TRVI Nasdaq
- NRC Nasdaq
- Market Cap
- TRVI 383.4M
- NRC 394.2M
- IPO Year
- TRVI 2019
- NRC N/A
- Fundamental
- Price
- TRVI $6.61
- NRC $12.99
- Analyst Decision
- TRVI Strong Buy
- NRC
- Analyst Count
- TRVI 8
- NRC 0
- Target Price
- TRVI $17.56
- NRC N/A
- AVG Volume (30 Days)
- TRVI 1.3M
- NRC 96.5K
- Earning Date
- TRVI 05-08-2025
- NRC 04-28-2025
- Dividend Yield
- TRVI N/A
- NRC 3.72%
- EPS Growth
- TRVI N/A
- NRC N/A
- EPS
- TRVI N/A
- NRC 1.02
- Revenue
- TRVI N/A
- NRC $141,298,000.00
- Revenue This Year
- TRVI N/A
- NRC N/A
- Revenue Next Year
- TRVI N/A
- NRC N/A
- P/E Ratio
- TRVI N/A
- NRC $13.16
- Revenue Growth
- TRVI N/A
- NRC N/A
- 52 Week Low
- TRVI $2.30
- NRC $9.76
- 52 Week High
- TRVI $7.39
- NRC $35.81
- Technical
- Relative Strength Index (RSI)
- TRVI 56.38
- NRC 57.23
- Support Level
- TRVI $6.37
- NRC $12.39
- Resistance Level
- TRVI $7.24
- NRC $13.29
- Average True Range (ATR)
- TRVI 0.42
- NRC 0.72
- MACD
- TRVI -0.01
- NRC 0.37
- Stochastic Oscillator
- TRVI 50.38
- NRC 78.59
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.